Literature DB >> 16930415

Associative Pavlovian conditioning leads to an increase in spinophilin-immunoreactive dendritic spines in the lateral amygdala.

Jason J Radley1, Luke R Johnson, William G M Janssen, Jeremiah Martino, Raphael Lamprecht, Patrick R Hof, Joseph E LeDoux, John H Morrison.   

Abstract

Changes in dendritic spine number and shape are believed to reflect structural plasticity consequent to learning. Previous studies have strongly suggested that the dorsal subnucleus of the lateral amygdala is an important site of physiological plasticity in Pavlovian fear conditioning. In the present study, we examined the effect of auditory fear conditioning on dendritic spine numbers in the dorsal subnucleus of the lateral amygdala using an immunolabelling procedure to visualize the spine-associated protein spinophilin. Associatively conditioned rats that received paired tone and shock presentations had 35% more total spinophilin-immunoreactive spines than animals that had unpaired stimulation, consistent with the idea that changes in the number of dendritic spines occur during learning and account in part for memory.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16930415     DOI: 10.1111/j.1460-9568.2006.04962.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  21 in total

Review 1.  Plastic synaptic networks of the amygdala for the acquisition, expression, and extinction of conditioned fear.

Authors:  Hans-Christian Pape; Denis Pare
Journal:  Physiol Rev       Date:  2010-04       Impact factor: 37.312

2.  Co-localization of caldesmon and calponin with cortical afferents, metabotropic glutamate and neurotrophic receptors in the lateral and central nuclei of the amygdala.

Authors:  Khristofor Agassandian; Martin D Cassell
Journal:  Brain Res       Date:  2008-06-11       Impact factor: 3.252

3.  IQGAP1 regulates NR2A signaling, spine density, and cognitive processes.

Authors:  Can Gao; Shanti F Frausto; Anita L Guedea; Natalie C Tronson; Vladimir Jovasevic; Katie Leaderbrand; Kevin A Corcoran; Yomayra F Guzmán; Geoffrey T Swanson; Jelena Radulovic
Journal:  J Neurosci       Date:  2011-06-08       Impact factor: 6.167

4.  D-Cycloserine Ameliorates Autism-Like Deficits by Removing GluA2-Containing AMPA Receptors in a Valproic Acid-Induced Rat Model.

Authors:  Han-Fang Wu; Po See Chen; Ya-Ting Hsu; Chi-Wei Lee; Tzu-Feng Wang; Yi-Ju Chen; Hui-Ching Lin
Journal:  Mol Neurobiol       Date:  2017-07-21       Impact factor: 5.590

5.  Models of care for late-life depression of the medically ill: examples from chronic obstructive pulmonary disease and stroke.

Authors:  Jimmy N Avari; George S Alexopoulos
Journal:  Am J Geriatr Psychiatry       Date:  2014-06-20       Impact factor: 4.105

6.  Amphetamine-associated contextual learning is accompanied by structural and functional plasticity in the basolateral amygdala.

Authors:  David J Rademacher; J Amiel Rosenkranz; Maud M Morshedi; Elyse M Sullivan; Gloria E Meredith
Journal:  J Neurosci       Date:  2010-03-31       Impact factor: 6.167

Review 7.  Molecular mechanisms of fear learning and memory.

Authors:  Joshua P Johansen; Christopher K Cain; Linnaea E Ostroff; Joseph E LeDoux
Journal:  Cell       Date:  2011-10-28       Impact factor: 41.582

Review 8.  The ubiquitin-proteasome system as a critical regulator of synaptic plasticity and long-term memory formation.

Authors:  Timothy J Jarome; Fred J Helmstetter
Journal:  Neurobiol Learn Mem       Date:  2013-04-25       Impact factor: 2.877

Review 9.  Structural and functional plasticity of dendritic spines - root or result of behavior?

Authors:  C D Gipson; M F Olive
Journal:  Genes Brain Behav       Date:  2016-10-02       Impact factor: 3.449

10.  Synaptic plasticity and NO-cGMP-PKG signaling regulate pre- and postsynaptic alterations at rat lateral amygdala synapses following fear conditioning.

Authors:  Kristie T Ota; Melissa S Monsey; Melissa S Wu; Glenn E Schafe
Journal:  PLoS One       Date:  2010-06-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.